Skip to search formSkip to main contentSkip to account menu

HRE 664

Known as: 4-Thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(4-(aminocarbonyl)phenoxy)-6-(1-hydroxyethyl)-7-oxo-, (5R-(5alpha,6alpha(R*)))-, HRE-664 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lactams

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Analytical and numerical solution of three-dimensional channel flow in presence of a sinusoidal fluid injection and a chemical reaction
2015
2015
Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment
Bortezomib, a novel proteasome inhibitor, has been approved for treating multiple myeloma and mantle cell lymphoma and studied… 
2010
2010
Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin.
2008
2008
DNA‐binding profiling of human hormone nuclear receptors via fluorescence correlation spectroscopy in a cell‐free system
2007
2007
HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc.
UNLABELLED The regulation of galectin-3 expression in skeletal tissues is not completely understood. Our studies indicate that… 
2007
2007
Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion.
2005
2005
Herpes Simplex Virus Amplicon Delivery of a Hypoxia-Inducible Soluble Vascular Endothelial Growth Factor Receptor (sFlk-1) Inhibits Angiogenesis and Tumor Growth in Pancreatic Adenocarcinoma
BackgroundTumor hypoxia induces vascular endothelial growth factor (VEGF) expression, which stimulates angiogenesis and tumor… 
2000
2000
Confidence measures for speech recognition and utterance verification
Esta investigacion esta dedicada al estudio e implantacion de metodos eficaces para medir los niveles de confianza de las… 
1987
1987
HRE 664, a new parenteral penem. I. Antibacterial activity in vitro.
The new penem antibiotic HRE 664 displays potent antibacterial activity in vitro against a broad spectrum of clinically relevant… 
1987
1987
HRE 664, a new parenteral penem. II. Evaluation of the pharmacokinetic behavior and the chemotherapeutic activity in animals.
The pharmacokinetic and chemotherapeutic properties of the new penem antibiotic HRE 664 (Fig. 1) were evaluated in experimental… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)